The Health Research Institute is offering this grant to bridge the gap between epidemiological discoveries and effective prevention strategies for substance use and addiction. This grant is for researchers aiming to translate findings from substance use epidemiology into tangible prevention interventions. Utilizing a phased R61/R33 mechanism, the initial R61 phase supports innovative epidemiological research, either through new data collection or analysis of existing data, to establish a robust foundation. The subsequent R33 phase then applies these findings to refine or develop targeted prevention interventions, increasing their impact or reaching new populations. Applicants must propose a Multi-Principal Investigator/Multi-Program Director structure, ensuring diverse expertise. A supplementary mechanism also fosters bidirectional translation, allowing existing projects to explore prevention hypotheses or deepen epidemiological understanding of interventions.
Opportunity ID: 344857
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-24-010 |
| Funding Opportunity Title: | Rapid Translation of Epidemiological Findings into Interventions to Prevent Substance Use and Addiction (R61/R33 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 12, 2022 |
| Last Updated Date: | Dec 12, 2022 |
| Original Closing Date for Applications: | Mar 15, 2023 |
| Current Closing Date for Applications: | Mar 15, 2023 |
| Archive Date: | Apr 20, 2023 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Public and State controlled institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) Special district governments City or township governments State governments County governments Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Private institutions of higher education Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The goal of this initiative is to address the structural incentives that limit translation from epidemiology into prevention science using a two-pronged approach. The phased R61/R33 mechanism will support innovative epidemiologic research using either primary data collection or analysis of existing data related to substance use and addiction in the R61 phase to provide the foundation for a targeted prevention intervention in the R33 phase. The R33 phase would apply the findings from the R61 phase to either a) adapt or target an existing intervention to increase effect size or reach a new population or b) develop a novel intervention to address a new prevention target. Applicants would be required to use an MPI/MPD structure so that there is a PI with relevant expertise to lead the different components of the project. The supplement mechanism will capitalize on bidirectional translational science wherein existing epidemiological projects can submit proposals to test prevention hypotheses as well as prevention interventions can submit proposals for additional epidemiological inquiry to help contextualize their findings. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-010.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 344857 Full Announcement-RFA-DA-24-010 -> RFA-DA-24-010-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00278878 | Feb 15, 2023 | Mar 15, 2023 | View |
Package 1
Mandatory forms
344857 RR_SF424_5_0-5.0.pdf
344857 PHS398_CoverPageSupplement_5_0-5.0.pdf
344857 RR_OtherProjectInfo_1_4-1.4.pdf
344857 PerformanceSite_4_0-4.0.pdf
344857 RR_KeyPersonExpanded_4_0-4.0.pdf
344857 RR_Budget_3_0-3.0.pdf
344857 PHS398_ResearchPlan_5_0-5.0.pdf
344857 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
344857 RR_SubawardBudget30_3_0-3.0.pdf
344857 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
